(Q38050186)

27 August 2017

title

Can treating persistent inflammation limit protein energy wasting? (English)

1 reference

27 August 2017

1

1 reference

27 August 2017

publication date

9 October 2012

1 reference

27 August 2017

1 reference

27 August 2017

volume

26

1 reference

27 August 2017

issue

1

1 reference

27 August 2017

page(s)

16-19

1 reference

The origins of cachexia in acute and chronic inflammatory diseases.

27 August 2017

cites work

1 reference

IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia--the good, the bad, and the ugly

21 January 2018

1 reference

Inflammation as a risk factor and target for therapy in chronic kidney disease

21 January 2018

1 reference

Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profile

21 January 2018

1 reference

Circulating follistatin in patients with chronic kidney disease: implications for muscle strength, bone mineral density, inflammation, and survival

21 January 2018

1 reference

Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease

21 January 2018

1 reference

Fish consumption and omega-3 fatty acid status and determinants in long-term hemodialysis.

21 January 2018

1 reference

Gamma-tocopherol and docosahexaenoic acid decrease inflammation in dialysis patients.

21 January 2018

1 reference

High dietary fiber intake is associated with decreased inflammation and all-cause mortality in patients with chronic kidney disease

21 January 2018

1 reference

Low-fructose diet lowers blood pressure and inflammation in patients with chronic kidney disease

21 January 2018

1 reference

Effect of allopurinol in chronic kidney disease progression and cardiovascular risk

21 January 2018

1 reference

Inflammation in end-stage renal disease--what have we learned in 10 years?

21 January 2018

1 reference

Efficacy of rosuvastatin among men and women with moderate chronic kidney disease and elevated high-sensitivity C-reactive protein: a secondary analysis from the JUPITER (Justification for the Use of Statins in Prevention-an Intervention Trial Evalu

21 January 2018

1 reference

Effect of atorvastatin on inflammation and outcome in patients with type 2 diabetes mellitus on hemodialysis

21 January 2018

1 reference

Rosuvastatin and cardiovascular events in patients undergoing hemodialysis

21 January 2018

1 reference

Effect of renin angiotensin system blockade on pentraxin 3 levels in type-2 diabetic patients with proteinuria

21 January 2018

1 reference

Combined therapy with renin-angiotensin system and calcium channel blockers in type 2 diabetic hypertensive patients with proteinuria: effects on soluble TWEAK, PTX3, and flow-mediated dilation

21 January 2018

1 reference

Effects of aliskiren on blood pressure and the predictive biomarkers for cardiovascular disease in hemodialysis-dependent chronic kidney disease patients with hypertension.

21 January 2018

1 reference

Cholecalciferol supplementation alters calcitriol-responsive monocyte proteins and decreases inflammatory cytokines in ESRD.

21 January 2018

1 reference

Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters

21 January 2018

1 reference

Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial

21 January 2018

1 reference

Short-term treatment with sevelamer increases serum fetuin-a concentration and improves endothelial dysfunction in chronic kidney disease stage 4 patients

21 January 2018

1 reference

Effects of sevelamer on HbA1c, inflammation, and advanced glycation end products in diabetic kidney disease

21 January 2018

1 reference

Interleukin-1-receptor antagonist in type 2 diabetes mellitus

21 January 2018

1 reference

IL-1β receptor antagonist reduces inflammation in hemodialysis patients

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/SDI.12020

1 reference

27 August 2017

1 reference